Hong Kong Pharma Digital Technology Holdings Limited (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
2.340
-0.080 (-3.31%)
At close: Jan 24, 2025, 4:00 PM
2.300
-0.040 (-1.71%)
After-hours: Jan 24, 2025, 7:57 PM EST

Company Description

Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the OTC pharmaceutical business in Hong Kong and Mainland China.

It provides OTC pharmaceutical cross-border e-commerce supply chain; and procurement and distribution services.

It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors.

Hong Kong Pharma Digital Technology Holdings Limited was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Hong Kong Pharma Digital Technology Holdings Limited
Country Hong Kong
Founded 2016
IPO Date Jan 15, 2025
Industry Integrated Freight & Logistics
Sector Industrials
Employees 19
CEO Lap Sun Wong

Contact Details

Address:
Well Town Industrial Building, Room B1, 5h Floor
Yau Tong, 999077
Hong Kong
Phone 852 2618 9289
Website 9zt.hk

Stock Details

Ticker Symbol HKPD
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
IPO Price $4.00
CIK Code 0002007702
ISIN Number KYG6365B1041
SIC Code 5122

Key Executives

Name Position
Lap Sun Wong Chief Executive Officer and Chairman of the Board of Directors
Zhifang Zhang Director
Man Bun Kwok Chief Financial Officer
Yingying Li Chief Operating Officer

Latest SEC Filings

Date Type Title
Jan 17, 2025 6-K Report of foreign issuer
Jan 15, 2025 424B4 Prospectus
Jan 13, 2025 CERT Certification by an exchange approving securities for listing
Jan 8, 2025 8-A12B Registration of securities
Dec 20, 2024 EFFECT Notice of Effectiveness
Dec 10, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Dec 3, 2024 UPLOAD Filing
Nov 27, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Nov 22, 2024 FWP Free Writing Prospectus
Nov 21, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers